Skip to content
DataLookout
Menu

NCT07249567

Comparison of Patients With COPD and PRISM

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 20 words Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 91 participants (planned 60)
    • Primary completion date changed from estimate of Sep 5, 2026 to Mar 5, 2026
    • Study completion date changed from estimate of Nov 30, 2026 to Mar 30, 2026
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Upper extremity exercise capacity
Timeframe: Baseline
Lower extremity exercise capacity
Timeframe: Baseline
Peripheral muscle strength
Timeframe: Baseline
Muscle oxygenation
Timeframe: Baseline
Respiratory Muscle Strength
Timeframe: Baseline
Respiratory Muscle Endurance
Timeframe: Baseline
Dyspnea
Timeframe: Baseline
Clinical symptoms
Timeframe: Baseline

Secondary (5)

Pulmonary function (Forced vital capacity (FVC)
Pulmonary function (Forced expiratory volume in the first second (FEV1)
Pulmonary function (FEV1 / FVC)
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))
Pulmonary function (Peak flow rate (PEF))

Arms and interventions

Patients with COPD

Patients with chronic obstructive pulmonary disease will be included.

Patients with PRISm

Patients with preserved ratio impaired spirometry will be included.

Control

Healthy controls will be included.

Sites

1 site in 1 country

  • Karabuk University, Physiotherapy and Rehabilitation Application and Research CenterKarabük, Turkey (Türkiye)